Baker Ellis Asset Management LLC Has $8.03 Million Position in Stryker Co. (NYSE:SYK)

Baker Ellis Asset Management LLC reduced its holdings in shares of Stryker Co. (NYSE:SYK) by 0.9% during the 1st quarter, Holdings Channel.com reports. The fund owned 22,444 shares of the medical technology company’s stock after selling 196 shares during the period. Stryker accounts for about 1.2% of Baker Ellis Asset Management LLC’s portfolio, making the stock its 23rd largest position. Baker Ellis Asset Management LLC’s holdings in Stryker were worth $8,032,000 as of its most recent filing with the SEC.

Other institutional investors have also made changes to their positions in the company. Burkett Financial Services LLC acquired a new position in Stryker in the fourth quarter valued at about $25,000. Farmers & Merchants Trust Co of Chambersburg PA boosted its position in Stryker by 203.3% in the fourth quarter. Farmers & Merchants Trust Co of Chambersburg PA now owns 91 shares of the medical technology company’s stock valued at $27,000 after buying an additional 61 shares in the last quarter. Rogco LP acquired a new position in Stryker in the fourth quarter valued at about $30,000. DSM Capital Partners LLC acquired a new position in Stryker in the fourth quarter valued at about $34,000. Finally, HBC Financial Services PLLC acquired a new position in Stryker in the fourth quarter valued at about $37,000. 77.09% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities analysts have commented on SYK shares. Piper Sandler boosted their price target on shares of Stryker from $375.00 to $380.00 and gave the company an “overweight” rating in a research report on Wednesday, May 1st. Needham & Company LLC upgraded shares of Stryker from a “hold” rating to a “buy” rating and set a $392.00 price target on the stock in a research report on Wednesday, May 22nd. The Goldman Sachs Group began coverage on shares of Stryker in a research note on Thursday, May 30th. They issued a “neutral” rating and a $372.00 target price for the company. Wells Fargo & Company boosted their target price on shares of Stryker from $364.00 to $381.00 and gave the stock an “overweight” rating in a research note on Wednesday, May 1st. Finally, Roth Mkm boosted their target price on shares of Stryker from $348.00 to $405.00 and gave the stock a “buy” rating in a research note on Wednesday, May 1st. Four equities research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company. According to data from MarketBeat, Stryker has an average rating of “Moderate Buy” and an average price target of $370.58.

Stryker Trading Up 0.1 %

Shares of SYK traded up $0.51 on Friday, reaching $340.25. 1,894,420 shares of the company’s stock were exchanged, compared to its average volume of 1,082,587. The company has a current ratio of 1.71, a quick ratio of 0.99 and a debt-to-equity ratio of 0.56. The stock has a market capitalization of $129.62 billion, a P/E ratio of 38.84, a price-to-earnings-growth ratio of 2.68 and a beta of 0.92. The business has a 50 day moving average price of $337.38 and a two-hundred day moving average price of $333.66. Stryker Co. has a 12 month low of $249.98 and a 12 month high of $361.41.

Stryker (NYSE:SYK) last issued its quarterly earnings data on Tuesday, April 30th. The medical technology company reported $2.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.36 by $0.14. The firm had revenue of $5.24 billion during the quarter, compared to analysts’ expectations of $5.10 billion. Stryker had a net margin of 16.03% and a return on equity of 23.05%. The business’s revenue for the quarter was up 9.7% on a year-over-year basis. During the same quarter in the previous year, the company earned $2.14 earnings per share. Research analysts anticipate that Stryker Co. will post 11.95 earnings per share for the current year.

Stryker Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 31st. Investors of record on Friday, June 28th will be issued a dividend of $0.80 per share. This represents a $3.20 dividend on an annualized basis and a yield of 0.94%. The ex-dividend date is Friday, June 28th. Stryker’s dividend payout ratio is currently 36.53%.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.